What sector does Poly Medicure Limited belong to?

Poly Medicure Limited operates in the Healthcare sector, specifically the Medical Equipment & Supplies industry, and is listed on the NSE.

What is the current share price of POLYMED?

As of the latest available quote, POLYMED traded at ₹1,738.50. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of POLYMED?

Poly Medicure Limited has a price-to-earnings (P/E) ratio of about 55.86. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of POLYMED?

The market capitalisation of Poly Medicure Limited is approximately ₹17,622 Cr.

Is Poly Medicure Limited profitable?

For its latest reported financial year, Poly Medicure Limited recorded a net profit margin of about 17.12%.

Does POLYMED pay a dividend?

Poly Medicure Limited does not currently show a dividend yield in our data.

What is the return on equity (ROE) of POLYMED?

Poly Medicure Limited has a return on equity (ROE) of about 9.02%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of POLYMED?

Over the past 52 weeks, POLYMED has traded between a low of ₹1,182.00 and a high of ₹2,107.80.

Poly Medicure Limited

POLYMED NSE Healthcare Medical Equipment & Supplies

Nifty 500 Smallcap 250

₹1,738.50

-0.53%

Delayed · cached 15 min

Fair value analysis

POLYMED

Poly Medicure Limited

₹1,747.70

Close used for this calculation

₹879.22Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

40/100

Profitability21/25

Returns2/25

Balance Sheet11/25

Efficiency6/25

Growth9/25

Average

Quality radar

Consensus fair value

₹879.22

Above FV

▼ -49.7% against the close used

Model range ₹230.68 – ₹1,395.82

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹230.68Fair value₹879.22Bull₹1,395.82

FairClose

52-week traded range

52W low ₹1,191.1052W high ₹2,065.40

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Poly Medicure Limited closed at ₹1,747.70, 98.8% above the consensus fair value of ₹879.22 drawn from 9 valuation models.

Financial DNA score 40/100 — Average. P/E of 55.1x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₹630.80

-63.9%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=9%, r=10%, tg=3%, n=10yr

Graham Number

₹467.42

-73.3%

√(22.5 × EPS × BVPS)

EPS=31.78, BVPS=305.54 · outside Graham range (P/E 55.1, P/B 5.7) — asset-light, treat as a rough floor

Graham Formula

₹1,395.82

-20.1%

EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate

g=19.4%, FD=7%

P/E Fair Value

₹1,198.11

-31.4%

EPS × 37.7x (sector P/E)

EPS=31.78, Sector P/E=37.7x

Peter Lynch (PEG)

₹616.53

-64.7%

EPS × Growth% (PEG = 1 is fair)

EPS=31.78, g=19.4%

EV/EBITDA

₹968.17

-44.6%

(EBITDA × 18x − Net Debt) ÷ Shares

EBITDA=5.62B

Book Value (P/B)

₹230.68

-86.8%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=305.54, ROE=9%, g=6%, r=10%

Reverse DCF

₹1,747.70

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 20.8% | Historical: 19.4%

Margin of Safety

₹692.28

-60.4%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=923.04, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer